SethIanRosenthalMD

Dermatopathology, Anatomic Pathology, Clinical Pathology

Laboratory of Dermatopathology

Dr. Rosenthal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1 Cranberry Hl
Ste 105
Lexington, MA 02421
Phone+1 800-325-7284

Fax+1 205-579-9387

University of Texas M D Anderson Cancer CenterFellowship, Dermatopathology, 2002 - 2003
University of Texas M.D. Anderson Cancer CenterSelective Pathology, 2001 - 2002
Albany Medical CenterResidency, Pathology-Anatomic and Clinical, 1997 - 2001
University of Alabama HospitalInternship, Transitional Year, 1996 - 1997
Albany Medical CollegeClass of 1996
Columbia UniversityPremedical Post baccalaureate Program, 1990 - 1991
University of PennsylvaniaB.A., Religious Studies, 1985 - 1988

PubMed

98 citations
Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
Peter L. Depowski, Seth I Rosenthal, Thomas P. Brien, Scott Stylos, Rebecca L. Johnson
Modern Pathology. 2000-05-01
228 citations
Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer.
Peter L. Depowski, Seth I Rosenthal, Jeffrey S. Ross
Modern Pathology. 2001-07-01
35 citations
Comparison of HER-2/neu oncogene amplification detected by fluorescence in situ hybridization in lobular and ductal breast cancer.
Seth I Rosenthal, Peter L. Depowski, Christine E. Sheehan, Jeffrey S. Ross
Applied Immunohistochemistry & Molecular Morphology. 2002-03-01

Journal Articles

Squamo-melanocytic tumor: A case report and further insights into its possible histogenesis.
Jour G, Paniz Mondolfi A, Reidy J, Cressey B, Rosenthal S, Am J Dermatopathol, 5/6/2013
Dermal Pleomorphic Liposarcoma.
Tariq Al-Zaid, M.D., Gretchen Frieling, M.D., Seth Rosenthal, M.D., J Cutan Pathol, 4/15/2013
Erythema Elevatum Diutinum: Report of a Unique Case and Novel Treatment with Topical Dapsone Gel 5% (ACZONE).
Gretchen W. Frieling, M.D., Scott J.M. Lim, D.O., and Seth Rosenthal, M.D., J Drugs Dermatol, 4/1/2013
Validation of Anti-PHH3 Immunostain in Fibrohistiocytic Tumors: A Study of 96 Cases.
G. Jour, A.P. Paniz, D. Lucido, and S. Rosenthal, 10/1/2012
Comparison of HER-2/neu Oncogene Amplification Detected by Fluorescence In Situ Hybridization in Lobular and Ductal Breast Cancer.
Rosenthal, S. I., Depowski, P. L., Sheehan, C. E., and Ross, J. S., Appl. Immunohistochem. Mol. Morphol., 1/1/2002
Loss of Expression of the PTEN Gene Protein Product is Associated with Poor Outcome in Breast Cancer.
PL Depowski, SI Rosenthal, JS Ross, Modern Pathology, 1/1/2001
Prognostic Significance of Topoisomerase II Alpha (Topo II) Expression in Breast Cancer.
PL Depowski, SI Rosenthal, TP Brien, S Stylos, RL Johnson, JS Ross, Modern Pathology, 1/1/2000
Join now to see all

Abstracts/Posters

High Grade Primary Cutaneous Angiosarcoma of Hip with Predominant Epithelioid Morphology.
A. Ahmad, M.D., M. Mahmoodi, M.D., A. Solky, M.D., S. Rosenthal, M.D., 48th annual ASDP meeting., 10/1/2011